AAAAAA
Results: 1-25/33
Authors:
KNOLL A
LOCK G
JILG W
HARTMANN A
Citation: A. Knoll et al., HEMOCHROMATOSIS CYS-282-TYR MUTATION IN HEPATITIS-C - HISTOPATHOLOGICAL EVALUATION, Hepatology, 28(4), 1998, pp. 2036-2036
Authors:
PEPPERL S
BENNINGERDORING G
MODROW S
WOLF H
JILG W
Citation: S. Pepperl et al., IMMEDIATE-EARLY TRANSACTIVATOR RTA OF EPSTEIN-BARR-VIRUS (EBV) SHOWS MULTIPLE EPITOPES RECOGNIZED BY EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES, Journal of virology (Print), 72(11), 1998, pp. 8644-8649
Authors:
KNOLL A
KREUZPAINTNER B
KREUZPAINTNER E
JILG W
LOCK G
HARTMANN A
Citation: A. Knoll et al., HEMOCHROMATOSIS MUTATION IN HEPATITIS-C - HISTOPATHOLOGY, Gastroenterology (New York, N.Y. 1943), 115(5), 1998, pp. 1307-1308
Authors:
JILG W
Citation: W. Jilg, HEPATITIS-B VACCINE FOR CHILDREN, Deutsche Medizinische Wochenschrift, 122(38), 1997, pp. 1164-1164
Authors:
SCHATZL HM
SIEGER E
JILG W
NITSCHKO H
ZACHOVAL R
Citation: Hm. Schatzl et al., VARIABILITY OF THE HEPATITIS-B SURFACE PROTEIN IN HBV-INFECTED LIVER-TRANSPLANT RECIPIENTS, Journal of biomedical science, 4(4), 1997, pp. 146-154
Authors:
MAIWALD H
JILG W
BOCK HL
LOSCHER T
VONSONNENBURG F
Citation: H. Maiwald et al., LONG-TERM PERSISTENCE OF ANTI-HAV ANTIBODIES FOLLOWING ACTIVE IMMUNIZATION WITH HEPATITIS-A VACCINE, Vaccine, 15(4), 1997, pp. 346-348
Authors:
CLEMENS R
SANGER R
KRUPPENBACHER J
HOBEL W
STANBURY W
BOCK HL
JILG W
Citation: R. Clemens et al., BOOSTER IMMUNIZATION OF LOWRESPONDERS AND NONRESPONDERS AFTER A STANDARD 3 DOSE HEPATITIS-B VACCINE SCHEDULE - RESULTS OF A POSTMARKETING SURVEILLANCE, Vaccine, 15(4), 1997, pp. 349-352
Authors:
JILG W
Citation: W. Jilg, IMMUNOPROPHYLAXIS OF VIRAL-HEPATITIS, Zeitschrift fur Gastroenterologie, 35, 1997, pp. 585-590
Authors:
JILG W
Citation: W. Jilg, IMMUNOPROPHYLAXIS OF VIRAL-HEPATITIS, Zeitschrift fur Gastroenterologie, 35(7), 1997, pp. 585-590
Authors:
ARDJAH H
BAENKLER HW
FROSNER G
GURTLER L
JILG W
PLASSMANN E
RING J
VONSONNENBURG F
TYMPNER KD
Citation: H. Ardjah et al., STANDARD IMMUNOGLOBULINS - STATUS-REPORT, Der Internist, 38(5), 1997, pp. 494-496
Authors:
JILG W
Citation: W. Jilg, HEPATITIS-C, Deutsche Medizinische Wochenschrift, 121(11), 1996, pp. 355-355
Authors:
JILG W
Citation: W. Jilg, SIGNIFICANCE OF IMPORTED HEPATITIS-B VIRUS-INFECTIONS, Archives of virology, 1996, pp. 181-183
Authors:
PALITZSCH KD
HOLSTEGE A
STARCKE U
HOTTENTRAGER B
SCHOLMERICH J
JILG W
Citation: Kd. Palitzsch et al., PREVALENCE OF HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTION IN GERMANY, Gastroenterology, 110(4), 1996, pp. 1289-1289
Authors:
BOCK HL
KRUPPENBACHER J
SANGER R
HOBEL W
CLEMENS R
JILG W
Citation: Hl. Bock et al., IMMUNOGENICITY OF A RECOMBINANT HEPATITIS-A VACCINE IN ADULTS, Archives of internal medicine, 156(19), 1996, pp. 2226-2231
Authors:
JILG W
Citation: W. Jilg, IMMUNIZATION OF ADULTS, Deutsche Medizinische Wochenschrift, 120(3), 1995, pp. 49-50
Authors:
JILG W
Citation: W. Jilg, INTRODUCTION TO CURRENT CONTROL OF HEPATITIS-B AS A COMMUNITY-HEALTH RISK, Vaccine, 13, 1995, pp. 40-40
Authors:
JILG W
Citation: W. Jilg, SELECTIVE RISK GROUP STRATEGIES IN EUROPE, Vaccine, 13, 1995, pp. 44-46
Authors:
KANE M
JILG W
BELL A
GULLY PR
PAPAEVANGELOU G
DUMA R
Citation: M. Kane et al., CURRENT CONTROL OF HEPATITIS-B AS A COMMUNITY-HEALTH RISK - SESSION 2- DISCUSSION, Vaccine, 13, 1995, pp. 50-51
Authors:
JUST M
JILG W
Citation: M. Just et W. Jilg, WORKSHOP GROUP - GERMANY AND SWITZERLAND, Vaccine, 13, 1995, pp. 92-92
Authors:
JILG W
SIEGER E
ZACHOVAL R
SCHATZL H
Citation: W. Jilg et al., INDIVIDUALS WITH ANTIBODIES AGAINST HEPATITIS-B CORE ANTIGEN AS THE ONLY SEROLOGICAL MARKER FOR HEPATITIS-B INFECTION - HIGH PERCENTAGE OF CARRIERS OF HEPATITIS-B AND HEPATITIS-C VIRUS, Journal of hepatology, 23(1), 1995, pp. 14-20
Authors:
BOGEDAIN C
WOLF H
MODROW S
STUBER G
JILG W
Citation: C. Bogedain et al., SPECIFIC CYTOTOXIC T-LYMPHOCYTES RECOGNIZE THE IMMEDIATE-EARLY TRANSACTIVATOR ZTA OF EPSTEIN-BARR-VIRUS, Journal of virology, 69(8), 1995, pp. 4872-4879
Authors:
JILG W
Citation: W. Jilg, HEPATITIS-A VACCINATION, Deutsche Medizinische Wochenschrift, 119(51-52), 1994, pp. 1800-1800
Authors:
MAYER J
REISCHL U
JILG W
Citation: J. Mayer et al., CLINICAL-SIGNIFICANCE OF THE POLYMERASE C HAIN-REACTION IN THE DIAGNOSIS OF INFECTIOUS-DISEASES, Deutsche Medizinische Wochenschrift, 119(47), 1994, pp. 1625-1629
Authors:
JILG W
Citation: W. Jilg, HEPATITIS-B - SIGNIFICANCE FOR TRANSFUSIO N MEDICINE, Infusionstherapie und Transfusionsmedizin, 21, 1994, pp. 20-26
Authors:
JILG W
BOGEDAIN C
MAIRHOFER H
GU SY
WOLF H
Citation: W. Jilg et al., THE EPSTEIN-BARR VIRUS-ENCODED GLYCOPROTEIN GP-110 (BALE-4) CAN SERVEAS A TARGET FOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC), Virology, 202(2), 1994, pp. 974-977